Journal of Neuro-Oncology

, Volume 142, Issue 2, pp 283–290 | Cite as

Efficacy of gamma knife radiosurgery in brain metastases of primary gynecological tumors

  • Zjiwar H. A. SadikEmail author
  • Laurens V. Beerepoot
  • Patrick E. J. Hanssens
Clinical Study



Gynecological brain metastases (BM) are rare and usually develop as part of widespread disseminated disease. Despite treatment, the majority of these patients do not survive > 1 year due to advanced extracranial disease. The use of Gamma Knife Radiosurgery (GKRS) for gynecological BM is not well known. The goal of this study is to evaluate the efficacy of GKRS for gynecological BM.


We performed a retrospective study of patients with gynecological BM who underwent GKRS between 2002 and 2015. A total of 41 patients were included. Outcome measures were local tumor control (LC), development of new BM and/or leptomeningeal disease, overall intracranial progression free survival (PFS) and survival.


LC was 100%, 92%, 80%, 75% and 67% at 3, 6, 9, 12 and 15 months, respectively. PFS was 90%, 61%, 41%, 23% and 13% at 3, 6, 9, 12 and 15 months, respectively. During follow-up (FU), 18 (44%) patients had intracranial progression. Distant BM occurred in 29% of the patients. Local recurrence and distant recurrence occurred after a mean FU time of 15.5 (2.6–71.9) and 11.4 (2–40) months, respectively. Thirty-one (76%) patients died due to extracranial tumor progression and only 2 (5%) patients died due to progressive intracranial disease. The overall mean survival from time of GKRS was 19 months (1–109). The 6-month, 1-year, and 2-year survival rate from the time of GKRS were 71%, 46%, and 22%, respectively.


GKRS is a good treatment option for controlling gynecological BM. As most patients die due to extracranial tumor progression, their survival might improve with better systemic treatment options in addition to GKRS.


Gynecological tumors Gynecological brain metastases Gamma knife radiosurgery 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

For this type of study formal consent is not required.


  1. 1.
    Larson DM, Copeland LJ, Moser RP, Malone JM Jr, Gershenson DM, Wharton JT (1986) Central nervous system metastases in epithelial ovarian carcinoma. Obstet Gynecol 68:746–750PubMedGoogle Scholar
  2. 2.
    Kolomainen DF, Larkin JM, Badran M, A’Hern RP, King DM, Fisher C, Bridges JE, Blake PR, Barton DP, Shepherd JH, Kaye SB, Gore ME (2002) Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol 20:982–986. CrossRefPubMedGoogle Scholar
  3. 3.
    Barker GH, Orledge J, Wiltshaw E (1981) Involvement of the central nervous system in patients with ovarian carcinoma. Br J Obstet Gynaecol 88:690–694CrossRefPubMedGoogle Scholar
  4. 4.
    Cohen ZR, Suki D, Weinberg JS, Marmor E, Lang FF, Gershenson DM, Sawaya R (2004) Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neuro-oncol 66:313–325CrossRefGoogle Scholar
  5. 5.
    Tay SK, Rajesh H (2005) Brain metastases from epithelial ovarian cancer. Int J Gynecol Cancer 15:824–829. CrossRefPubMedGoogle Scholar
  6. 6.
    Chen YL, Cheng WF, Hsieh CY, Chen CA (2011) Brain metastasis as a late manifestation of ovarian carcinoma. Eur J Cancer Care 20:44–49. CrossRefGoogle Scholar
  7. 7.
    Dauplat J, Nieberg RK, Hacker NF (1987) Central nervous system metastases in epithelial ovarian carcinoma. Cancer 60:2559–2562CrossRefPubMedGoogle Scholar
  8. 8.
    LeRoux PD, Berger MS, Elliott JP, Tamimi HK (1991) Cerebral metastases from ovarian carcinoma. Cancer 67:2194–2199CrossRefPubMedGoogle Scholar
  9. 9.
    Suzuki M, Tsukagoshi S, Ohwada M, Koumura Y, Sato I (1999) A patient with brain metastasis from ovarian cancer who showed complete remission after multidisciplinary treatment. Gynecol Oncol 74:483–486. CrossRefPubMedGoogle Scholar
  10. 10.
    Kaminsky-Forrett MC, Weber B, Conroy T, Spaeth D (2000) Brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer 10:366–371CrossRefPubMedGoogle Scholar
  11. 11.
    Sanderson A, Bonington SC, Carrington BM, Alison DL, Spencer JA (2002) Cerebral metastasis and other cerebral events in women with ovarian cancer. Clin Radiol 57:815–819CrossRefPubMedGoogle Scholar
  12. 12.
    Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S (2002) Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol Oncol 85:487–492CrossRefPubMedGoogle Scholar
  13. 13.
    Pectasides D, Aravantinos G, Fountzilas G, Kalofonos C, Efstathiou E, Karina M, Pavlidis N, Farmakis D, Economopoulos T, Dimopoulos MA (2005) Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature. Anticancer Res 25:3553–3558PubMedGoogle Scholar
  14. 14.
    Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP (2008) Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol 108:505–509. CrossRefPubMedGoogle Scholar
  15. 15.
    Sehouli J, Pietzner K, Harter P, Munstedt K, Mahner S, Hasenburg A, Camara O, Wimberger P, Boehmer D, Buehling KJ, Richter R, El Khalfaoui K, Oskay-Ozcelik G (2010) Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol 21:2201–2205. CrossRefPubMedGoogle Scholar
  16. 16.
    Aalders JG, Abeler V, Kolstad P (1984) Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17:85–103CrossRefPubMedGoogle Scholar
  17. 17.
    De Porre PM, Subandono Tjokrowardojo AJ (1992) Brain metastases of endometrial carcinoma. Case report and review of literature. Strahlentherapie Onkologie: Organ der Deutschen Rontgengesellschaft [et al] 168:100–101Google Scholar
  18. 18.
    Cormio G, Lissoni A, Losa G, Zanetta G, Pellegrino A, Mangioni C (1996) Brain metastases from endometrial carcinoma. Gynecol Oncol 61:40–43. CrossRefPubMedGoogle Scholar
  19. 19.
    Gien LT, Kwon JS, D’Souza DP, Radwan JS, Hammond JA, Sugimoto AK, Carey MS (2004) Brain metastases from endometrial carcinoma: a retrospective study. Gynecol Oncol 93:524–528. CrossRefPubMedGoogle Scholar
  20. 20.
    Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA (2007) Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: a retrospective analysis and literature review. Gynecol Oncol 107:79–85. CrossRefPubMedGoogle Scholar
  21. 21.
    Ogawa K, Yoshii Y, Aoki Y, Nagai Y, Tsuchida Y, Toita T, Kakinohana Y, Tamaki W, Iraha S, Adachi G, Hirakawa M, Kamiyama K, Inamine M, Hyodo A, Murayama S (2008) Treatment and prognosis of brain metastases from gynecological cancers. Neurologia medico-chirurgica 48:57–62; discussion 62–53CrossRefPubMedGoogle Scholar
  22. 22.
    O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR (2003) A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol 55:1169–1176CrossRefGoogle Scholar
  23. 23.
    Matsunaga S, Shuto T, Sato M (2016) Gamma knife surgery for metastatic brain tumors from gynecologic cancer. World Neurosurg 89:455–463. CrossRefPubMedGoogle Scholar
  24. 24.
    Shin HK, Kim JH, Lee do H, Cho YH, Kwon do H, Roh SW (2016) Clinical outcomes of gamma knife radiosurgery for metastatic brain tumors from gynecologic cancer: prognostic factors in local treatment failure and survival. J Korean Neurosurg Soc 59:392–399. CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Keller A, Ismail R, Potrebko PS, Pepe J, Wu M, Saigal K, Biagioli M, Shridhar R, Holloway R, Field M, Rao NG (2016) Role of Gamma Knife(R) radiosurgery for the treatment of brain metastases from gynecological cancers. Cureus 8:e947. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Monaco E IIIrd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD (2008) Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer 113:2610–2614. CrossRefPubMedGoogle Scholar
  27. 27.
    Ogino A, Hirai T, Fukushima T, Serizawa T, Watanabe T, Yoshino A, Katayama Y (2012) Gamma knife surgery for brain metastases from ovarian cancer. Acta neurochirurgica 154:1669–1677. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Jawahar A, Matthew RE, Minagar A, Shukla D, Zhang JH, Willis BK, Ampil F, Nanda A (2004) Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis. J Neurosurg 100:842–847. CrossRefPubMedGoogle Scholar
  29. 29.
    Pan HC, Sheehan J, Stroila M, Steiner M, Steiner L (2005) Gamma knife surgery for brain metastases from lung cancer. J Neurosurg 102 Suppl:128–133CrossRefPubMedGoogle Scholar
  30. 30.
    Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2002) Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 97:1276–1281. CrossRefPubMedGoogle Scholar
  31. 31.
    Firlik KS, Kondziolka D, Flickinger JC, Lunsford LD (2000) Stereotactic radiosurgery for brain metastases from breast cancer. Ann Surg Oncol 7:333–338CrossRefPubMedGoogle Scholar
  32. 32.
    Lederman G, Wronski M, Fine M (2001) Fractionated radiosurgery for brain metastases in 43 patients with breast carcinoma. Breast Cancer Res Treat 65:145–154CrossRefPubMedGoogle Scholar
  33. 33.
    Muacevic A, Kreth FW, Tonn JC, Wowra B (2004) Stereotactic radiosurgery for multiple brain metastases from breast carcinoma. Cancer 100:1705–1711. CrossRefPubMedGoogle Scholar
  34. 34.
    Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD (1998) Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 83:344–353CrossRefPubMedGoogle Scholar
  35. 35.
    Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2003) Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98:342–349. CrossRefPubMedGoogle Scholar
  36. 36.
    Shuto T, Inomori S, Fujino H, Nagano H (2006) Gamma knife surgery for metastatic brain tumors from renal cell carcinoma. J Neurosurg 105:555–560. CrossRefPubMedGoogle Scholar
  37. 37.
    Kasper E, Ippen F, Wong E, Uhlmann E, Floyd S, Mahadevan A (2017) Stereotactic radiosurgery for brain metastasis from gynecological malignancies. Oncol Lett 13:1525–1528. CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Geisler JP, Geisler HE (1995) Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol 57:246–249. CrossRefPubMedGoogle Scholar
  39. 39.
    Stein M, Steiner M, Klein B, Beck D, Atad J, Kuten A, Robinson E, Goldsher D (1986) Involvement of the central nervous system by ovarian carcinoma. Cancer 58:2066–2069CrossRefPubMedGoogle Scholar
  40. 40.
    Cormio G, Maneo A, Parma G, Pittelli MR, Miceli MD, Bonazzi C (1995) Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review. Ann Oncol 6:571–574CrossRefPubMedGoogle Scholar
  41. 41.
    Shepard MJ, Fezeu F, Lee CC, Sheehan JP (2014) Gamma knife radiosurgery for the treatment of gynecologic malignancies metastasizing to the brain: clinical article. J Neuro-oncol 120:515–522. CrossRefGoogle Scholar
  42. 42.
    Corn BW, Mehta MP, Buatti JM, Wolfson AH, Greven KM, Kim RY, Dunton CJ, Loeffler JS (1999) Stereotactic Irradiation: potential new treatment method for brain metastases resulting from ovarian cancer. Am J Clin Oncol 22:143–146CrossRefPubMedGoogle Scholar
  43. 43.
    Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V (2017) Whole-brain radiotherapy for brain metastases: evolution or revolution? J Clin Oncol. CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044. CrossRefPubMedGoogle Scholar
  45. 45.
    Chougule PB, Burton-Williams M, Saris S, Zheng Z, Ponte B, Noren G, Alderson L, Friehs G, Wazer D, Epstein M Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol 48: 114
  46. 46.
    Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol 53:519–526CrossRefGoogle Scholar
  47. 47.
    Watanabe A, Shimada M, Kigawa J, Iba T, Oishi T, Kanamori Y, Terakawa N (2005) The benefit of chemotherapy in a patient with multiple brain metastases and meningitis carcinomatosa from ovarian cancer. Int J Clin Oncol 10:69–71. CrossRefPubMedGoogle Scholar
  48. 48.
    Cooper KG, Kitchener HC, Parkin DE (1994) Cerebral metastases from epithelial ovarian carcinoma treated with carboplatin. Gynecol Oncol 55:318–323. CrossRefPubMedGoogle Scholar
  49. 49.
    Nakagawa H, Fujita T, Kubo S, Tokiyoshi K, Yamada M, Kanayama T, Hagiwara Y, Nakanomyo H, Hiraoka M (1996) Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor. Cancer Chemother Pharmacol 37:317–326. CrossRefPubMedGoogle Scholar
  50. 50.
    McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, Gold MA, Guruswamy S, Mannel RS (2001) Ovarian cancer metastatic to the brain: what is the optimal management? J Surg Oncol 78:194–200; discussion 200 – 191CrossRefPubMedGoogle Scholar
  51. 51.
    Hardy JR, Harvey VJ (1989) Cerebral metastases in patients with ovarian cancer treated with chemotherapy. Gynecol Oncol 33:296–300CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Gamma Knife CenterElisabeth-Tweesteden HospitalTilburgThe Netherlands
  2. 2.Department of NeurosurgeryElisabeth-Tweesteden HospitalTilburgThe Netherlands
  3. 3.Department of Medical OncologyElisabeth-Tweesteden HospitalTilburgThe Netherlands
  4. 4.Department of NeurosurgeryErasmus Medical CenterRotterdamThe Netherlands

Personalised recommendations